Alembic Pharma Gets USFDA Approval

  Published 1 year ago

Alembic Pharmaceuticals has received final approval from the USFDA for its Amlodipine and Atorvastatin Tablets USP. This allows the company to market a generic version of the drug in the US market.

  • USFDA approved Alembic's ANDA.
  • Amlodipine & Atorvastatin tablets approved.
  • Expands Alembic's US generic portfolio.

You might like these

India Sees Foreign Investment Revival

Torrent Pharma Gets Clean Inspection Report

Amber Group Q1 Profit Soars 48%

Wipro Unveils ESG Roadmap

Gold Nears $3420 on Fed Cut Hopes

Brigade Hotel Ventures Makes Weak Debut

Nuvama Stock Surges on Warburg Pincus Buyout Report

News that matters the most ⚡